Xeris Biopharma Holdings, Inc. · NASDAQ:XERS
The Vanguard Group reported a 6.74% stake in Xeris Biopharma Holdings, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 6.74% stake in Xeris Biopharma Holdings, Inc., 11,186,677 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 6.74%
- Shares
- 11,186,677
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 6.74% | 11,186,677 |
Source
Related
- Xeris Biopharma Holdings, Inc.
- The Vanguard Group
- Xeris Biopharma Holdings, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Hecht Beth · Oct 2, 2026
- Form 4 · McCulloch Kevin · Oct 2, 2026
- Form 4 · Pieper Steven · Oct 2, 2026
- Form 4 · McCulloch Kevin · Sep 29, 2026
- Form 4 · McCulloch Kevin · Sep 1, 2026